GFAP and Alzheimer disease: In the brain of patients with AD, gliosis is marked by an increase in activated microglia and reactive astrocytes near the sites of Aβ plaques [73,74], and astrocyte disruption results in the easy release of GFAP from the tissue into the blood [75].